COMPARATIVE ANALYSIS OF THE RANGE OF PENICILLINS USED IN THE TREATMENT OF CYSTITIS
Abstract
Objective. Comparative analysis of the range of penicillin medicines used for cystitis treatment in accordance with the instructions for medical use/leaflets and regulatory documents of the Ministry of Health of the Russian Federation.
Material and methods. Based on the data from the State Register of Medicines (14.01.2025), the marketing indicators of the pharmaceutical penicillin market have been determined and presented using mathematical and graphical methods, and the assortment renewal index has been calculated.
Results. It was revealed that 64% of all medicinal products of penicillins can be used to treat cystitis based on the instructions in patients of different age groups, and 54% in pediatric practice in accordance with modern standards of medical care and clinical recommendations. It was determined that the most common name is amoxicillin+clavulanic acid, manufactured by «Sintez» and «Ruzpharma» (16% and 13% respectively), dosage forms are powder for intravenous and intramuscular administration and film-coated tablets (17% and 23% respectively).
Conclusion. The pharmaceutical market of penicillin drugs is represented by a wide range, while the average value of the threeyear renewal index of 35% indicates its compliance with the requirements of modern medicine.
About the Authors
T. G. Afanasyeva
ФГБОУ ВО «Воронежский государственный медицинский университет имени Н.Н. Бурденко» Минздрава России
Russian Federation
Russian Federation
E. S. Tkachuk
ФГБОУ ВО «Воронежский государственный медицинский университет имени Н.Н. Бурденко» Минздрава России
Russian Federation
Russian Federation
References
1. Gosudarstvennyi reestr lekarstvennykh sredstv (the State Register of medicines). [Elektronnyi resurs] - https://grls.rosminzdrav.ru/default.aspx (data obrashcheniya: 14.01.2025) (In Russ.)
2. Klinicheskie rekomendatsii Minzdrava Rossii «Infektsiya mochevykh putei» - vozrastnaya kategoriya: deti, 2024. (Urinary tract infection - аge group: children, 2024) [Elektronnyi resurs] - https://cr.minzdrav.gov.ru/preview-cr/281_3 (data obrashcheniya: 14.01.2025) (In Russ.)
3. Khodyreva L.A., Zaitsev A.V., Bernikov A.N. [et al.] Acute and recurrent cystitis. What do we know? RMJ. 2020;28(11):69-74 (In Russ.)
4. Otchety DSM Group – «Farmatsevticheskii rynok Rossii» (Pharmaceutical market of Russia), 2024. [Elektronnyi resurs] - https://dsm.ru/news-reports/ (data obrashcheniya: 18.01.2025) (In Russ.)
5. Sinyakova L. A., Kosova I. V., Loran O. B., Barsegyan V. A. Posobie dlya vrachei-terapevtov po ostromu tsistitu (neoslozhnennaya infektsiya mochevykh putei) (kod po MKB-10 N30.0) (Manual for general practitioners on acute cystitis (uncomplicated urinary tract infection) (ICD-10 code N30.0)). Farmateka. 2024;31(1):198-207 (In Russ.) DOI 10.18565
6. Zakharenkov I.A., Rachina S.A., Kozlov R.S., Belkova Yu.A. Consumption of systemic antibiotics in the Russian Federation in 2017- 2021. Clinical Microbiology and Antimicrobial Chemotherapy. 2022;24(3):220-225. (In Russ.) DOI 10.36488
7. Prikaz MZ RF N 647n ot 31.08.2016. «Ob utverzhdenii Pravil nadlezhashchei aptechnoi praktiki lekarstvennykh preparatov dlya meditsinskogo primeneniya». [Elektronnyi resurs] - https://www.consultant.ru/document/cons_doc_LAW_210618/(data obrashcheniya: 02.02.2025) (In Russ.)
8. Prikaz MZ RF N 678n ot 12.12.2023. «Ob utverzhdenii standarta meditsinskoi pomoshchi detyam pri infektsii mochevyvodyashchikh putei (diagnostika, lechenie i dispansernoe nablyudenie)». [Elektronnyi resurs] - https://www.consultant.ru/document/cons_doc_LAW_467981/ (data obrashcheniya: 25.01.2025) (In Russ.)
9. Rasporyazhenie Pravitel'stva RF ot 12.10.2019 N 2406-r <Ob utverzhdenii perechnya zhiznenno neobkhodimykh i vazhneishikh lekarstvennykh preparatov, a takzhe perechnei lekarstvennykh preparatov dlya meditsinskogo primeneniya i minimal'nogo assortimenta lekarstvennykh preparatov, neobkhodimykh dlya okazaniya meditsinskoi pomoshchi> [Elektronnyi resurs] - https://www.consultant.ru/document/cons_doc_LAW_335635/ (data obrashcheniya: 15.02.2025).
10. Registr lekarstvennykh sredstv Rossii. [Elektronnyi resurs] - https://www.rlsnet.ru/ (data obrashcheniya: 11.01.2025) (In Russ.)
11. Reshenie Soveta Evraziiskoi ekonomicheskoi komissii № 78 ot 03.11.2016 «O Pravilakh registratsii i ekspertizy lekarstvennykh sredstv dlya meditsinskogo primeneniya» (In Russ.)
12. Afanasyeva T.G., Makhinova E.N., Lavrova N.N., Tkachuk E.S. The modern pharmaceutical market of antibacterial drugs for the treatment of infections in outpatient settings. Medical & pharmaceutical journal «PULSE». 2024;26(2):5-11. (In Russ.)
13. Khalimova A.A. Review of the antibiotics market and evaluation of its development prospects. Medical & pharmaceutical journal «PULSE». 2023; 2:77-83. DOI 10.26787/nydha-2686-6838-2024-26-2-5-11 (In Russ.)
14. Apolikhin O.I., Wagenlehner F., Voytko D.A. [et al.] Epidemiological study of the prevalence of cystitis in women of the Voronezh region. Experimental and clinical urology. 2021;14(1):10-18. (In Russ.) DOI 10.29188/2222-8543-2021-14-1-10-18.
15. Bono MJ, Leslie SW, Reygaert WC. Uncomplicated Urinary Tract Infections. 2023 Nov 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29261874 (in Engl.)
16. The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD). [Electronic resource] - https://atcddd.fhi.no/atc_ddd_index/ (date of request: 23.01.2025 г.) (in Engl.)
17. Yip DW, Gerriets V. Penicillin. 2024 Feb 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32119447 (in Engl.)
Review
For citations:
Afanasyeva T.G., Tkachuk E.S. COMPARATIVE ANALYSIS OF THE RANGE OF PENICILLINS USED IN THE TREATMENT OF CYSTITIS. Bashkortostan Medical Journal. 2025;20(4):71-76. (In Russ.)
Views:
15
Email this article 
